vs
Alector, Inc.（ALEC）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
NexPoint Real Estate Finance, Inc.的季度营收约是Alector, Inc.的1.8倍（$11.1M vs $6.2M），NexPoint Real Estate Finance, Inc.同比增速更快（-48.8% vs -88.5%）
Alector是一家临床阶段生物制药企业，专注于神经退行性疾病的免疫疗法研发，管线覆盖阿尔茨海默病、额颞叶痴呆、帕金森病等未被满足的医疗需求，主要在美国运营，与全球药企合作推进候选药物的临床试验。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
ALEC vs NREF — 直观对比
营收规模更大
NREF
是对方的1.8倍
$6.2M
营收增速更快
NREF
高出39.7%
-88.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.2M | $11.1M |
| 净利润 | — | $24.0M |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | — | 216.6% |
| 营收同比 | -88.5% | -48.8% |
| 净利润同比 | -1696.9% | 58.7% |
| 每股收益（稀释后） | — | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALECNREF
| Q4 25 | $6.2M | $11.1M | ||
| Q3 25 | $3.3M | $12.5M | ||
| Q2 25 | $7.9M | $12.1M | ||
| Q1 25 | $3.7M | $11.5M | ||
| Q4 24 | $54.2M | $21.7M | ||
| Q3 24 | $15.3M | $12.5M | ||
| Q2 24 | $15.1M | $6.7M | ||
| Q1 24 | $15.9M | $-12.8M |
净利润ALECNREF
| Q4 25 | — | $24.0M | ||
| Q3 25 | $-34.7M | $50.9M | ||
| Q2 25 | $-30.5M | $22.3M | ||
| Q1 25 | $-40.5M | $26.0M | ||
| Q4 24 | $-2.1M | $15.2M | ||
| Q3 24 | $-42.2M | $23.3M | ||
| Q2 24 | $-38.7M | $12.1M | ||
| Q1 24 | $-36.1M | $-14.6M |
营业利润率ALECNREF
| Q4 25 | — | — | ||
| Q3 25 | -1153.6% | — | ||
| Q2 25 | -433.6% | — | ||
| Q1 25 | -1216.5% | — | ||
| Q4 24 | -13.4% | — | ||
| Q3 24 | -315.7% | — | ||
| Q2 24 | -302.4% | — | ||
| Q1 24 | -275.0% | — |
净利率ALECNREF
| Q4 25 | — | 216.6% | ||
| Q3 25 | -1063.4% | 407.0% | ||
| Q2 25 | -387.7% | 184.5% | ||
| Q1 25 | -1101.6% | 225.6% | ||
| Q4 24 | -3.8% | 69.9% | ||
| Q3 24 | -275.2% | 186.4% | ||
| Q2 24 | -256.4% | 179.7% | ||
| Q1 24 | -227.0% | 114.3% |
每股收益（稀释后）ALECNREF
| Q4 25 | — | $0.47 | ||
| Q3 25 | $-0.34 | $1.14 | ||
| Q2 25 | $-0.30 | $0.54 | ||
| Q1 25 | $-0.41 | $0.70 | ||
| Q4 24 | $-0.02 | $0.71 | ||
| Q3 24 | $-0.43 | $0.74 | ||
| Q2 24 | $-0.40 | $0.40 | ||
| Q1 24 | $-0.38 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $256.0M | $31.1M |
| 总债务越低越好 | $10.0M | $771.2M |
| 股东权益账面价值 | $30.6M | $388.0M |
| 总资产 | $293.2M | $5.3B |
| 负债/权益比越低杠杆越低 | 0.33× | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资ALECNREF
| Q4 25 | $256.0M | $31.1M | ||
| Q3 25 | $291.1M | $17.9M | ||
| Q2 25 | $307.3M | $9.1M | ||
| Q1 25 | $354.6M | $19.2M | ||
| Q4 24 | $413.4M | $3.9M | ||
| Q3 24 | $457.2M | $34.7M | ||
| Q2 24 | $503.3M | $4.3M | ||
| Q1 24 | $562.1M | $13.5M |
总债务ALECNREF
| Q4 25 | $10.0M | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | $10.0M | $799.3M | ||
| Q3 24 | — | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
股东权益ALECNREF
| Q4 25 | $30.6M | $388.0M | ||
| Q3 25 | $57.7M | $375.4M | ||
| Q2 25 | $71.2M | $348.2M | ||
| Q1 25 | $94.6M | $343.7M | ||
| Q4 24 | $126.8M | $336.5M | ||
| Q3 24 | $118.9M | $335.8M | ||
| Q2 24 | $150.6M | $327.5M | ||
| Q1 24 | $178.9M | $327.1M |
总资产ALECNREF
| Q4 25 | $293.2M | $5.3B | ||
| Q3 25 | $335.3M | $5.3B | ||
| Q2 25 | $356.4M | $5.4B | ||
| Q1 25 | $408.3M | $5.4B | ||
| Q4 24 | $468.3M | $5.4B | ||
| Q3 24 | $516.0M | $5.7B | ||
| Q2 24 | $570.7M | $6.6B | ||
| Q1 24 | $635.5M | $7.1B |
负债/权益比ALECNREF
| Q4 25 | 0.33× | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | 0.08× | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-184.0M | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | $-184.1M | — |
| 自由现金流率自由现金流/营收 | -2951.3% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | $-326.5M | — |
8季度趋势，按日历期对齐
经营现金流ALECNREF
| Q4 25 | $-184.0M | $-4.5M | ||
| Q3 25 | $-32.5M | $8.1M | ||
| Q2 25 | $-49.0M | $3.3M | ||
| Q1 25 | $-60.8M | $16.0M | ||
| Q4 24 | $-55.0M | $4.4M | ||
| Q3 24 | $-50.7M | $14.7M | ||
| Q2 24 | $-62.8M | $-7.5M | ||
| Q1 24 | $-61.3M | $17.7M |
自由现金流ALECNREF
| Q4 25 | $-184.1M | — | ||
| Q3 25 | $-32.5M | — | ||
| Q2 25 | $-49.1M | — | ||
| Q1 25 | $-60.8M | — | ||
| Q4 24 | $-55.2M | — | ||
| Q3 24 | $-50.9M | — | ||
| Q2 24 | $-63.1M | — | ||
| Q1 24 | $-61.9M | — |
自由现金流率ALECNREF
| Q4 25 | -2951.3% | — | ||
| Q3 25 | -997.6% | — | ||
| Q2 25 | -623.0% | — | ||
| Q1 25 | -1655.0% | — | ||
| Q4 24 | -101.8% | — | ||
| Q3 24 | -332.1% | — | ||
| Q2 24 | -418.6% | — | ||
| Q1 24 | -389.3% | — |
资本支出强度ALECNREF
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 3.4% | — |
现金转化率ALECNREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
